Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: A randomized trial in three African countries

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Sartorius, Benn K D ^a,b   Chersich, Matthew F ^a,c   Mwaura, Mary ^d,h   Meda, Nicolas ^e,h   Temmerman, Marleen ^c   Newell, Marie L ^b   Farley, Timothy M M ^f   Luchters, Stanley ^a,c,g,h   Dioulasso, Bobo ^h   Faso, Burkina ^h   Fao, Paulin ^h   Ky Zerbo, Odette ^h   Gouem, Clarisse ^h   Somda, Paulin ^h   Hien, Hervé ^h   Ouedraogo, Patrice Elysée ^h   Kania, Dramane ^h   Sanou, Armande ^h   Kossiwavi, Ida Ayassou ^h   Sanogo, Bintou ^h   Ouedraogo, Moussa ^h   Siribie, Issa ^h   Valéa, Diane ^h   Ouedraogo, Sayouba ^h   Somé, Roseline ^h   Rouet, François ^h   Rollins, Nigel ^h   McFetridge, Lynne ^h   Naidu, Kevi ^h   Reyners, Marcel ^h   Irungu, Eunice ^h   Katingima, Christine ^h   Ouattara, Gina ^h   Mandaliya, Kishor ^h   Wambua, Sammy ^h   Thiongo, Mary ^h   Nduati, Ruth ^h   Kose, Judith ^h   Njagi, Ephantus ^h   Mwaura, Peter ^h   Newell, Marie Louise ^h   Mepham, Stephen ^h   Viljoen, Johannes ^h   Bland, Ruth ^h   Mthethwa, Londiwe ^h   more..

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c GHENT UNIVERSITY   (Belgium)

^d International Centre for Reproductive Health Kenya   (Kenya)

^e CENTRE MURAZ   (Burkina Faso)

^f Sigma 3 Services Sarl Scientific and Statistical Solutions   (Switzerland)

^g BURNET INSTITUTE   (Australia)

^h NONE

Author keywords

Anaemia; Drug toxicity; HIV; Pregnancy; Sub Saharan Africa; Zidovudine

Indexed keywords

ANTHELMINTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; FOLIC ACID; HEMOGLOBIN; IRON; LAMIVUDINE; LOPINAVIR; MULTIVITAMIN; NEVIRAPINE; RITONAVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICA; ANEMIA; ARTICLE; BREAST FEEDING; BURKINA FASO; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; KENYA; LABOR; MAJOR CLINICAL STUDY; MALARIA; MATERNAL DISEASE; PERINATAL PERIOD; PREGNANT WOMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SINGLE DRUG DOSE; SOCIOECONOMICS; SOUTH AFRICA; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; AFRICA SOUTH OF THE SAHARA; BLOOD; EPIDEMIOLOGY; HIV INFECTIONS; INFANT; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL;

ADULT; AFRICA SOUTH OF THE SAHARA; ANEMIA; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KAPLAN-MEIER ESTIMATE; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIDOVUDINE;

EID: 84887027905     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-522     Document Type: Article

References (48)

1. UNICEF, United Nations University, World Health Organization Iron deficiency anaemia: assessment, prevention, and control: a guide for programme managers 2001, Geneva, Switzerland: WHO, UNICEF, United Nations University, World Health Organization.
2. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach 2006, Geneva, Switzerland: World Health Organization, Department of HIV/AIDS, World Health Organization.
3. Meda N, Mandelbrot L, Cartoux M, Dao B, Ouangre A, Dabis F. Anaemia during pregnancy in Burkina Faso, West Africa, 1995-96: prevalence and associated factors. Bulletin of the World Health Organization 1999, 77:916-922. 2557753, 10612887.
4. Antelman G, Msamanga G, Spiegelman D, Urassa E, Narh R, Hunter D, Fawzi W. Nutritional factors and infectious disease contribute to anemia among pregnant women with Human Immunodeficiency Virus in Tanzania. Journal of Nutrition 2000, 130:1950-1957.
5. Uneke C, Duhlinska D, Igbinedion E. Prevalence and public health significance of HIV infection and anemia among pregnant women attending antenatal clinics in southeastern Nigeria. Journal of Health Population and Nutrition 2007, 25:328-335.
6. Haggaz A, Radi E, Adam I. Anaemia and low birth weight in Western Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010, 104:234-236. 10.1016/j.trstmh.2009.07.013, 19709703.
7. Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol 2009, 2(3):186-192. 2760896, 19826576.
8. Desai M, Ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007, 7(2):93-104. 10.1016/S1473-3099(07)70021-X, 17251080.
9. World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach 2010, Geneva, Switzerland: WHO Press, World Health Organization, World Health Organization.
10. Chersich MF, Luchters SM, Yard E, Othigo JM, Kley N, Temmerman M. Morbidity in the first year postpartum among HIV-infected women in Kenya. Int J Gynaecol Obstet 2008, 100(1):45-51. 10.1016/j.ijgo.2007.06.053, 17900585.
11. World Health Organization. Regional Office for Africa Health Situation Analysis in the African Region 2011, Geneva, Switzerland: Atlas of Health Statistics, World Health Organization. Regional Office for Africa.
12. Saving Mothers 2008-2010 Fifth Report on Confidential Enquiries into Maternal Deaths in South Africa http://www.doh.gov.za/docs/reports/2012/savingmothersshort.pdf.
13. Black RE, Allen LH, Bhutta ZA, Caulfield LE, De Onis M, Ezzati M, Mathers C, Rivera J. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008, 371(9608):243-260. 10.1016/S0140-6736(07)61690-0, 18207566.
14. Sarin A. Severe anaemia of pregnancy, recent experience. Int J Gynaecol Obstet 1995, 50:S45-S49.
15. MacLeod M. Retrospective follow-up of maternal deaths and their associated risk factors in a rural district of Tanzania. Trop Med Int Health 1998, 3:130-137. 10.1046/j.1365-3156.1998.00174.x, 9537275.
16. van den Broek N. Anaemia in pregnancy in developing countries. Review. British journal of obstetrics and gynaecology 1998, 105:385-390. 10.1111/j.1471-0528.1998.tb10120.x, 9609262.
17. Richman D, Fischl M, Grieco M, Gottlieb M, Volberding P, Laskin O, Leedom J, Groopman J, Mildvan D, Hirsch M, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987, 317(4):192-197. 10.1056/NEJM198707233170402, 3299090.
18. Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 1990, 322(14):941-949. 10.1056/NEJM199004053221401, 1969115.
19. Ssali F, Stohr W, Munderi P, Reid A, Walker AS, Gibb DM, Mugyenyi P, Kityo C, Grosskurth H, Hakim J, et al. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther 2006, 11(6):741-749.
20. Hoffmann CJ, Fielding KL, Charalambous S, Sulkowski MS, Innes C, Thio CL, Chaisson RE, Churchyard GJ, Grant AD. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS 2008, 22(1):67-74. 10.1097/QAD.0b013e3282f2306e, 3724474, 18090393.
21. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok. Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999, 353(9155):773-780. 10.1016/S0140-6736(98)10411-7, 10459957.
22. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000, 343(14):982-991. 10.1056/NEJM200010053431401, 11018164.
23. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999, 353(9155):781-785. 10.1016/S0140-6736(98)10412-9, 10459958.
24. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mere-Enfant. Lancet 1999, 353(9155):786-792. 10.1016/S0140-6736(98)11046-2, 10459959.
25. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010, 362(24):2271-2281. 10.1056/NEJMoa0911486, 3440865, 20554982.
26. Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, Buonomo E, Scarcella P, Ceffa S, Paturzo G, et al. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes. AIDS 2011, 25(13):1611-1618. 10.1097/QAD.0b013e3283493ed0, 21673553.
27. Kesho Bora Study Group Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: The Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges. Contemporary Clinical Trials 2011, 1:74-85. Kesho Bora Study Group.
28. Kesho Bora Study Group Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defic Syndr 2010, 54(5):533-541. Kesho Bora Study Group.
29. Kesho Bora Study Group Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. The Lancet infectious diseases 2011, 11(3):171-180. Kesho Bora Study Group.
30. Kesho Bora Study Group Maternal HIV-1 disease progression 18-24 months post-delivery according to antiretroviral prophylaxis regimen (Triple-Antiretroviral Prophylaxis during pregnancy and breastfeeding Versus Zidovudine/Single-Dose Nevirapine Prophylaxis): the Kesho Bora randomized controlled trial. Clinical Infectious Diseases 2012, 55(3):60-449. Kesho Bora Study Group.
31. WHO Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings 2004, http://www.who.int/hiv/pub/mtct/guidelinesarv/en/index.html, WHO.
32. StataCorp Stata Statistical Software: Release 12. College Station, TX: StataCorp LP 2011, College Station, Texas, United States: StataCorp, StataCorp.
33. R Development Core Team R: a language and environment for statistical computing. R Foundation for Statistical Computing 2011, Vienna, Austria: R foundation for statistical computing, R Development Core Team.
34. Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician 2009, 79(3):203-208.
35. Fleming AF. Tropical obstetrics and gynaecology. 1. Anaemia in pregnancy in tropical Africa. Trans R Soc Trop Med Hyg 1989, 83(4):441-448. 10.1016/0035-9203(89)90241-1, 2694476.
36. Uneke CJ, Duhlinska DD, Igbinedion EB. Prevalence and public-health significance of HIV infection and anaemia among pregnant women attending antenatal clinics in south-eastern Nigeria. J Health Popul Nutr 2007, 25(3):328-335. 2754029, 18330066.
37. Andersen P, Gill D. Cox's regression model for counting processes: a large sample study. Annals of Statistics 1982, 10:1100-1120.
38. Wei L, Lin D, Weissfeld L. Regression and analysis of multivariable incomplete failure time data by modelling marginal distributions. Journal of the American Statistical Association 1989, 84:1065-1073.
39. Bristol DR. Clinical equivalence. Journal of biopharmaceutical statistics 1999, 9(4):549-561. 10.1081/BIP-100101195, 10576403.
40. Berhane K, Karim R, Cohen M, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts D, Levine A. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004, 37:1245-1252. 10.1097/01.qai.0000134759.01684.27, 15385731.
41. Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002, 34(2):260-266. 10.1086/338151, 11740716.
42. Moyle G, Sawyer W, Law M, Amin J, Hill A. Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clin Ther 2004, 26(1):92-97. 10.1016/S0149-2918(04)90009-4, 14996521.
43. Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998, 9(2):117-125. 10.1097/00001648-199803000-00004, 9504278.
44. Huang SS, Barbour JD, Deeks SG, Huang JS, Grant RM, Ng VL, McCune JM. Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy. Clin Infect Dis 2000, 30(3):504-510. 10.1086/313714, 10722435.
45. Levine A, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a large cohort of HIV infected women. Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2001, 26:28-35.
46. Mugisha JO, Shafer LA, Van der Paal L, Mayanja BN, Eotu H, Hughes P, Whitworth JA, Grosskurth H. Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health 2008, 13(6):788-794. 10.1111/j.1365-3156.2008.02069.x, 18384480.
47. Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009, 16:102. 10.1186/1423-0127-16-102, 2783029, 19922646.
48. Chersich MF, Kley N, Luchters SM, Njeru C, Yard E, Othigo MJ, Temmerman M. Maternal morbidity in the first year after childbirth in Mombasa Kenya; a needs assessment. BMC Pregnancy Childbirth 2009, 9:51. 10.1186/1471-2393-9-51, 2777848, 19891784.